|
GB9605437D0
(en)
*
|
1996-03-15 |
1996-05-15 |
Iaf Biochem Int |
Cytomegalovirus inhibiting compounds
|
|
HUP0001054A3
(en)
|
1997-08-06 |
2001-01-29 |
Daiichi Asubio Pharma Co Ltd |
1-aryl-1,8-naphthyridin-4-one derivative as type iv phosphodiesterase inhibitor
|
|
CA2285352A1
(en)
|
1998-01-29 |
1999-08-05 |
Suntory Limited |
1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase iv inhibitory activity
|
|
AU4849199A
(en)
*
|
1998-07-01 |
2000-01-24 |
Celgro |
Fungal growth inhibitors
|
|
US6248739B1
(en)
*
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
Quinolinecarboxamides as antiviral agents
|
|
CA2399741A1
(en)
|
2000-03-21 |
2001-11-01 |
Scott D. Larsen |
4-hydroxycinnoline-3-carboxyamides as antiviral agents
|
|
NZ521523A
(en)
|
2000-03-21 |
2004-05-28 |
Upjohn Co |
4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
|
|
KR20020081479A
(ko)
|
2000-03-21 |
2002-10-26 |
파마시아 앤드 업존 캄파니 |
항바이러스제인4-옥소-1,4-디히드로-3-신놀린카르복스아미드
|
|
KR20020093849A
(ko)
|
2000-03-21 |
2002-12-16 |
파마시아 앤드 업존 캄파니 |
항바이러스제로서의4-옥소-1,4-디히드로[1,8]나프티리딘-3-카르복스아미드
|
|
PE20011349A1
(es)
|
2000-06-16 |
2002-01-19 |
Upjohn Co |
1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
|
|
US6559145B2
(en)
*
|
2000-07-12 |
2003-05-06 |
Pharmacia & Upjohn Company |
Heterocycle carboxamides as antiviral agents
|
|
US6730682B2
(en)
*
|
2000-07-12 |
2004-05-04 |
Pharmacia & Upjohn Company |
Heterocycle carboxamides as antiviral agents
|
|
US6562822B2
(en)
|
2000-07-12 |
2003-05-13 |
Pharmacia & Upjohn Company |
Heterocyle carboxamides as antiviral agents
|
|
JP2004517860A
(ja)
*
|
2000-10-12 |
2004-06-17 |
メルク エンド カムパニー インコーポレーテッド |
Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類
|
|
AU1532802A
(en)
*
|
2000-10-12 |
2002-04-22 |
Merck & Co Inc |
Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
|
|
EP1326865B1
(en)
*
|
2000-10-12 |
2009-05-06 |
Merck & Co., Inc. |
Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
|
|
NZ526622A
(en)
|
2000-12-11 |
2006-07-28 |
Amgen Sf Llc |
CXCR3 antagonists
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
PE20020856A1
(es)
*
|
2001-02-13 |
2002-11-11 |
Aventis Pharma Gmbh |
1,2,3,4-tetrahidronaftil aminas aciladas
|
|
ATE303384T1
(de)
*
|
2001-05-24 |
2005-09-15 |
Merck Frosst Canada Inc |
1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
|
|
US6794379B2
(en)
|
2001-06-06 |
2004-09-21 |
Tularik Inc. |
CXCR3 antagonists
|
|
WO2003077857A2
(en)
*
|
2002-03-15 |
2003-09-25 |
Merck & Co., Inc. |
N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
|
|
IS7839A
(is)
*
|
2002-11-22 |
2004-05-23 |
Merck Frosst Canada Ltd. |
4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
|
|
WO2005009971A1
(ja)
*
|
2003-07-24 |
2005-02-03 |
Astellas Pharma Inc. |
キノロン誘導体又はその塩
|
|
CA2881078C
(en)
|
2004-06-24 |
2018-10-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
US8354427B2
(en)
*
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
DE102004035203A1
(de)
|
2004-07-21 |
2006-02-16 |
Bayer Healthcare Ag |
Substituierte Chinolone
|
|
DE102005030524A1
(de)
|
2005-06-30 |
2007-01-18 |
Aicuris Gmbh & Co. Kg |
Substituierte Chinolone II
|
|
TW200800983A
(en)
*
|
2005-09-14 |
2008-01-01 |
Janssen Pharmaceutica Nv |
5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
|
|
ATE486875T1
(de)
*
|
2005-11-10 |
2010-11-15 |
Chemocentryx Inc |
Substituierte chinolone und verwendungsverfahren
|
|
WO2007075901A2
(en)
*
|
2005-12-24 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Quinolin- 4 - one derivatives as modulators of abc transporters
|
|
LT1993360T
(lt)
|
2005-12-28 |
2017-06-12 |
Vertex Pharmaceuticals Incorporated |
N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
|
|
DE102006005861A1
(de)
|
2006-02-09 |
2007-08-23 |
Aicuris Gmbh & Co. Kg |
Substituierte Chinolone III
|
|
FR2917412B1
(fr)
|
2007-06-13 |
2009-08-21 |
Sanofi Aventis Sa |
Derives de 7-alkynyl, 1,8-naphthyridones, leur preparation et leur application en therapeutique
|
|
FR2917413B1
(fr)
|
2007-06-13 |
2009-08-21 |
Sanofi Aventis Sa |
Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique
|
|
NZ583878A
(en)
|
2007-09-14 |
2012-10-26 |
Vertex Pharma |
Modulators of ABC transporter and cystic fibrosis transmembrane conductance regulator (CFTR)
|
|
US12458635B2
(en)
|
2008-08-13 |
2025-11-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
WO2010097410A1
(en)
|
2009-02-24 |
2010-09-02 |
Respiratorius Ab |
Novel bronchodilating diazaheteroaryls
|
|
EP2226323A1
(en)
|
2009-02-27 |
2010-09-08 |
Almirall, S.A. |
New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
|
|
SI3330255T1
(sl)
|
2009-03-20 |
2021-03-31 |
Vertex Pharmaceuticals Incorporated |
Postopek izdelave regulatorja transmembranske prevodnosti pri cistični fibrozi
|
|
EP2380890A1
(en)
|
2010-04-23 |
2011-10-26 |
Almirall, S.A. |
New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
|
|
EP2394998A1
(en)
|
2010-05-31 |
2011-12-14 |
Almirall, S.A. |
3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
|
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
CN102643268B
(zh)
*
|
2011-12-30 |
2014-05-21 |
沈阳药科大学 |
喹啉类及噌啉类化合物及其应用
|
|
JP2015506360A
(ja)
*
|
2012-01-06 |
2015-03-02 |
ユニバーシティ・オブ・サウス・フロリダ |
組成物、使用方法および処置方法
|
|
EP2819670B1
(en)
|
2012-02-27 |
2026-05-20 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical Composition and Their Administration
|
|
CA2963945C
(en)
|
2014-10-07 |
2023-01-10 |
Vertex Pharmaceuticals Incorporated |
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
|
|
CN107998131B
(zh)
*
|
2017-12-27 |
2019-09-24 |
湖北工业大学 |
芳香酯类化合物用于制备抗adv-7病毒药物
|
|
CN111646941A
(zh)
*
|
2020-07-17 |
2020-09-11 |
天津科技大学 |
一种磺酰胺类衍生物及其制备方法和应用
|